UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009065
Receipt number R000010639
Scientific Title The effect of esomeprazole on acid suppression in Japanese-evaluation with the endoscopic gastrin test, EGT-
Date of disclosure of the study information 2012/10/15
Last modified on 2014/10/10 13:39:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of esomeprazole on acid suppression in Japanese-evaluation with the endoscopic gastrin test, EGT-

Acronym

The rate of acid suppression of administration of esomeprazole.

Scientific Title

The effect of esomeprazole on acid suppression in Japanese-evaluation with the endoscopic gastrin test, EGT-

Scientific Title:Acronym

The rate of acid suppression of administration of esomeprazole.

Region

Japan


Condition

Condition

Gastroesophageal reflux disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To compare the rate of acid suppression of esomeprazole administration in various dosage and timing.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the rate of acid suppression at the steady state(at 14:00 on day7) among each group.

Key secondary outcomes

To compare the rate of acid suppression of esomeprazole at 8:00 on day15* among each group.
*at 8:00 on day15: Twenty-four hours after last administration for once daily and 10 hours after last administration for twice daily
To evaluate the background factors that affect the acid suppression, such as H.pylori infecton, CYP2C19 polymophism in three groups.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

esomeprazole20mg before meal twice a day at 08:00 and 22:00-wash out 2-4week-esomeprazole20mg before meal once a day at 08:00.-wash out 2-4week esomeprazole10mg before meal once a day at 08:00

Interventions/Control_2

esomeprazole20mg before meal twice a day at 08:00 and 22:00-wash out 2-4week-esomeprazole10mg before meal once a day at 08:00-wash out 2-4week-esomeprazole20mg before meal once a day at 08:00

Interventions/Control_3

esomeprazole20mg before meal once a day at 08:00-wash out 2-4week-esomeprazole20mg before meal twice a day at 08:00 and 22:00-wash out 2-4week esomeprazole10mg bofore meal once a day at 08:00

Interventions/Control_4

esomeprazole20mg before meal once a day at 08:00-wash out 2-4week- esomeprazole10mg before meal once a day at 08:00-wash out 2-4week-esomeprazole20mg before meal twice a day at 08:00 and 22:00

Interventions/Control_5

esomeprazole10mg before meal once a day at 08:00-wash out 2-4week-esomeprazole20mg before meal twice a day at 08:00 and 22:00-wash out 2-4week-esomeprazole20mg before meal once a day at 08:00

Interventions/Control_6

esomeprazole10mg before meal once a day at 08:00-wah out 2-4wek-esomeprazole20mg before meal once a day at 08:00-wash out 2-4week-esomeprazole20mg before meal twice a day at 08:00 and 22:00

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male

Key inclusion criteria

1. healthy volunteer
1. Subjects provide written voluntary consent to participate in the study after sufficient written and oral explanation.

Key exclusion criteria

1. Subjects with past history of drug allergy
2. Subjects with hepatic, renal, or cardiac disorder
3. Subjects with a history of gastrectomy and/or vagotomy
4. Subjects who are on any treatment
5. Subjects who need to receive any drugs other thanthe study drug during the study.
6. Others as judged inappropriate by the investigator(s)

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoyuki Koike

Organization

Tohoku University Graduate Schooi of Medicine

Division name

Division of Gastroenterology

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Snedai

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Tomoyuki Koike

Organization

Tohoku University Graduate Schooi of Medicine

Division name

Division of Gastroenterology

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Snedai

TEL


Homepage URL


Email



Sponsor or person

Institute

Division of Gastroenterology, Tohoku University Graduate Schooi of Medicine

Institute

Department

Personal name



Funding Source

Organization

Non-profit Organization for Promotion of Gastrointestinal Disease Treatment Research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院 消化器内科


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 20 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 10 Month 09 Day

Last modified on

2014 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010639


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name